Circassia Pharmaceuticals PLC

(LSE, Stocks) 
Industry: Financials seperator Sector: General Finance
p 85.00 <%= Resources.Global.txtDown %>
Updated 19/06/2018
Change % -2.07% Stock price decreasing
Change -1.80 Stock price decreasing
Volume 15,465
High P 86.40
Low P 83.36
Open P 85.10
Prev close P 86.80
# of shares 333.47M
Market cap 28,345M GBX

Market closed
Circassia Pharmaceuticals PLC
Market is closed, opens at 08:00
Price development Latest 1 week 1 month 3 months 6 months 1 year
  85.00 -2.6% Stock price decreasing -8.6% Stock price decreasing -1.6% Stock price decreasing -12.4% Stock price decreasing 0.0% Stock price unchanged
Powered by TradingView

Company profile

Circassia Pharmaceuticals PLC is a biotechnology company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has three business segments, US AZ collaboration, Respiratory, and NIOX. The clear majority of revenue is generated by sales in the United States and European Union, followed by other international locations. The bulk of revenue is derived from Circassia's NIOX segment, which is focused on the diagnosis and management of asthma. The company sells its NIOX products direct to specialists in the U.S, U.K and Germany, while its partners market them elsewhere.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
20 June 2018 03:08:30
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180619.1 - EUROWEB1 - 2018-06-20 04:08:30 - 2018-06-20 03:08:30 - 1000 - Website: OKAY